EGFR and lung carcinoma: Moreover, overexpression of AXL has been demonstrated to enhance DTP cells’ activity and promote the emergence of the common EGFR mutation T790M in drug resistant lung cancer.145–147 The mechanism underlying this effect may involve AXL-induced activation of low-fidelity DNA polymerase and RAD18 through neddylation promotion.